More information on compounded medications here: and on compounded Semaglutide (Ozempic, Wegovy and Rybelsus) here: For more information on the side effects of these medications, please review this article:
SGLT2 inhibitors are usually initiated at standard doses without titration
What to Track After Calculating Progress Dose date, dose context, and missed or delayed doses Weight trend, goal progress, and non-scale victories Protein, hydration, meals, appetite, and movement Side effects such as nausea, constipation, reflux, fatigue, and headaches Questions for your prescriber if progress feels concerning or symptoms change How to Use Progress Data Before a Check-In Before a check-in, summarize the trend without hiding the context
Retatrutide (LY-3437943) is a next-generation triple incretin receptor agonist that simultaneously activates the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R)
At Fountain of Youth, patients receive a medical review that considers symptoms, goals, health history, lab context, medication use, and safety before any recommendation is made
Clinical Update 2/09/2026 Heavy Metals in Colostrum
